Table 1.
Vaccine | Targeted immunity | Animal testing | Clinical trial | Ref. | |
---|---|---|---|---|---|
Recombinant protein |
gpE1 and gpE2 Adjuvant: MF59 and MF75 |
Humoral immunity | Immunogenic in small animals; protects chimpanzees from acute or chronic infection |
Phase 1a; neutralizing antibodies and CD4+ T cell responses |
68,100,101 |
Core Adjuvant: Iscomatrix |
Cell-mediated immunity | Immunogenic in small animals and rhesus macaques |
Phase 1a; CD4+ and CD8+ T cell responses |
109,110 | |
gpE1 Adjuvant: alum |
Humoral immunity | Immunogenic in small animals; protects chimpanzees from acute or chronic infection |
Phase 1a; antibodies and CD4+ T cell responses; no longer in development |
111 | |
Core, NS3, NS4 and NS5 Adjuvant: Iscomatrix |
Cell-mediated immunity | Immunogenic in small animals; no protection from acute or chronic infection |
None | 101 | |
HCV-like particles containing core, gpE1 and gpE2 Adjuvant: AS01B |
Humoral and cell-mediated immunity |
Immunogenic in small animals; protects chimpanzees from chronic infection |
None | 89 | |
DNA and viral vector |
DNA prime and adeno expressing core and NS3–NS5 |
Cell-mediated immunity | Immunogenic in small animals; protects chimpanzees from chronic infection |
Phase 1/2 (NS3–NS5); CD4+ and CD8+ T cell responses |
67,102 |
DNA prime and adeno virus expressing core, E1, E2 and NS3– NS5 Adjuvant: IL-12 plasmid |
Humoral and cell-mediated immunity |
Immunogenic in small animals; protected chimpanzees from chronic infection |
None | 86 | |
DNA prime and MVA expressing core, E1, E2 and NS3, or NS3–NS5 |
Humoral and cell-mediated immunity |
Immunogenic in small animals; reduced peak viremia but did not protect chimpanzees from chronic infection |
Phase 1/2 as therapeutic vaccine; CD4+ and CD8+ T cell response |
81,83 | |
VV expressing core, E1, E2, p7, NS2 and NS3 |
Humoral and cell-mediated immunity |
Immunogenic in small animals; protected chimpanzees from chronic infection |
None | 80 | |
DNA expressing E2 | Humoral and cell-mediated immunity |
Immunogenic in small animals; protected chimpanzees from chronic infection |
None | 112 | |
DNA/recombinant protein |
DNA prime and protein boost (core, E1, E2 and NS3) Adjuvant: alum |
Humoral and cell-mediated immunity |
Immunogenic in small animals; protected chimpanzees from chronic infection |
None | 113 |
Only chimpanzee studies with two or more chimpanzees are listed.